Can Sputum Proteomics Find Biomarkers of Non-Tuberculous Mycobacterial Infection?
Can proteomics identify biomarkers of infection, disease severity, and treatment
response in patients with non-tuberculous mycobacterial lung infection?
Can proteomics identify biomarkers of infection, disease severity, and treatment
response in patients with non-tuberculous mycobacterial lung infection?
Asthma, having ever smoked, and chronic sinusitis are associated with increased odds for developing COPD before age 50 years among Hispanics.
Patients who have asthma or who have children who are at risk of developing asthma may wonder what they can do to prevent or control the condition. Does nutrition play a role in helping or worsening asthma, and what can you tell your patients?
Patients with active asthma or chronic obstructive pulmonary disease (COPD) are at increased risk for severe COVID-19 outcomes.
Respiratory devices (spacers, holding chambers, and reservoir bags) used with the treatment of asthma.
Chronic obstructive pulmonary disease (COPD) can have a significantly negative effect on a patient’s quality of life. What are risk factors for COPD that patients may experience earlier in life?
Trelegy Ellipta is now approved for the maintenance treatment of asthma in patients aged 18 years and older. Learn more about this new indication with our slideshow, complete drug monograph, and downloadable PDF.